EAU 2013 - Programme Book - YouMed

Monday
09.05 - 09.25 American Urological Association (AUA) Lecture Cellular-based therapy of urinary incontinence
234 Programme Book
L. Rodriguez, Los Angeles (US)
Aims and objectives
The aim of the lecture is to provide an update on the scientific advances made to date in cellular and stem
cell based therapies for the treatment of urinary incontinence. Available laboratory, pre-clinical and human
data will be reviewed. The objectives of the lecture are: 1) To help understand the clinical problem of SUI,
2) To help familiarise the audience with the potential benefits and pitfalls of stem cell based therapies, 3)
To provide an update on the current state of the art of cell based therapies for the treatment of urinary
incontinence.
09.25 - 10.05 Case discussion Sling, sphincter or balloon for male urinary incontinence
Moderator: J.W. Thüroff, Mainz (DE)
Sphincter K-D. Sievert, Tübingen (DE)
Balloon E. Chartier-Kastler, Paris (FR)
Sling P. Rehder, Innsbruck (AT)
Aims and objectives
The case discussion panel on surgical treatment options for male sphincteric incontinence aims at providing
detailed insight into mechanism of action of the different surgical strategies and their respective advantages
and disadvantages. This will eventually translate into defining criteria and/or tests for securing the indications
for each surgical technique and their respective limitations (contra-indications). Clinical examples are
presented and the best possible solutions for the individual cases are discussed.
10.05 - 10.45 Debate What the practising urologist needs to know about new therapies for LUTS. When, where and how
do they work?
Moderator: C.R. Chapple, Sheffield (GB)
Introduction to new therapies for lower urinary tract symptoms - setting the scene
C.R. Chapple, Sheffield (GB)
PDE5 inhibitors in the management of LUTS
M. Oelke, Hanover (DE)
Beta-3 agonist therapy
C.R. Chapple, Sheffield (GB)
Botulinum toxin therapy - which agent?
T.M. Kessler, Zürich (CH)
New avenues (neurotoxins and combination therapy) in treating the “BPH” patient
M.J. Speakman, Taunton (GB)
Discussion on how these new approaches relate to contemporary therapy
Aims and objectives
To provide the practising clinician with a comprehensive update on what they need to know about the latest
new therapies for LUTS.
The participants will provide a detailed overview on how these therapies are thought to work and the
evidence base relating to their use.
These treatments will be discussed against the backdrop of existing therapy and a detailed discussion will
be held as to:-
• the role of these therapies in the context of existing pharmacotherapy, will they replace it and if so in which
patients
• how they are thought to exert their effect